Announced Mon, 4 May · 18:12 IST
Aurobindo Pharma Limited has informed the Exchange about resignation of Dr. Sanjay Chaturvedi, CEO of Apitoria Pharma Private Limited, wholly owned subsidiary of the Company.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.8%1-day move
₹1374.90
prior close
₹1373.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.3+0.4+0.5+7.8+7.6+8.0+7.6+8.4+9.4+6.0+6.0+16.0—
Up moveDown movePending
AI summary
Aurobindo Pharma has informed exchanges that Dr. Sanjay Chaturvedi, CEO of Apitoria Pharma Private Limited, tendered his resignation effective May 4, 2026 (close of business hours). Apitoria Pharma is a wholly owned subsidiary of Aurobindo Pharma. Dr. Chaturvedi's stated reason for leaving is to pursue a different opportunity. The company has confirmed he has been relieved of his duties.
Likely market impact
This is a routine senior-level departure at a subsidiary level and is unlikely to have a direct material impact on Aurobindo Pharma's standalone operations. However, investors may monitor for successor appointment at Apitoria Pharma.